Home/bonesupport/Michael Diefenbeck
MD

Michael Diefenbeck

EVP Medical & Clinical Affairs, Chief Medical Officer

bonesupport

bonesupport Pipeline

DrugIndicationPhase
CERAMENT GInfection prevention in open fractures (Inpatient)Commercial
CERAMENT BONE VOID FILLERNon-infected bone voidsCommercial
CERAMENT VBone infection (Vancomycin-sensitive)Commercial (ex-U.S.)
CERTiFy Clinical TrialClinical evidence generationPost-Market Study